These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2568263

  • 1. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
    De Keyser J, Walraevens H, Convents A, Ebinger G, Vauquelin G.
    Eur J Pharmacol; 1989 Mar 29; 162(3):437-45. PubMed ID: 2568263
    [Abstract] [Full Text] [Related]

  • 2. What intracranial tissues in humans contain sumatriptan-sensitive serotonin 5-HT1-type receptors?
    De Keyser J, Vauquelin G, De Backer JP, De Vos H, Wilczak N.
    Neurosci Lett; 1993 Dec 24; 164(1-2):63-6. PubMed ID: 8152617
    [Abstract] [Full Text] [Related]

  • 3. [3H]SCH 23390 labels dopamine D-1 receptor sites in the rat kidney.
    Zdilar D, Lacković Z.
    Eur J Pharmacol; 1989 May 02; 164(1):159-62. PubMed ID: 2568936
    [Abstract] [Full Text] [Related]

  • 4. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
    Blurton PA, Wood MD.
    J Neurochem; 1986 May 02; 46(5):1392-8. PubMed ID: 3958711
    [Abstract] [Full Text] [Related]

  • 5. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ, Snyder SH.
    Brain Res; 1981 Mar 16; 208(2):339-47. PubMed ID: 7214150
    [Abstract] [Full Text] [Related]

  • 6. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
    Bischoff S, Heinrich M, Sonntag JM, Krauss J.
    Eur J Pharmacol; 1986 Oct 07; 129(3):367-70. PubMed ID: 3536532
    [Abstract] [Full Text] [Related]

  • 7. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
    Hicks PE, Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):339-42. PubMed ID: 6150862
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA, Humphrey PP, Lumley P.
    Br J Pharmacol; 1993 Oct 15; 110(2):539-47. PubMed ID: 8242228
    [Abstract] [Full Text] [Related]

  • 9. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 10. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
    Bischoff S, Heinrich M, Krauss J, Sills MA, Williams M, Vassout A.
    J Recept Res; 1988 Nov 26; 8(1-4):107-20. PubMed ID: 3290470
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM, MacKinnon AC, McGrath JC, Spedding M, Kilpatrick AT.
    Br J Pharmacol; 1990 Mar 26; 99(3):481-6. PubMed ID: 1970497
    [Abstract] [Full Text] [Related]

  • 12. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
    Ismaiel AM, Titeler M, Miller KJ, Smith TS, Glennon RA.
    J Med Chem; 1990 Feb 26; 33(2):755-8. PubMed ID: 2299641
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
    Phillips OM, Wood KM, Williams DC.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):299-306. PubMed ID: 3371401
    [Abstract] [Full Text] [Related]

  • 14. Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.
    Whiteford HA, Jarvis MR, Stedman TJ, Pond S, Csernansky JG.
    Life Sci; 1993 Feb 09; 53(4):371-6. PubMed ID: 8326822
    [Abstract] [Full Text] [Related]

  • 15. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    Cesura AM, Bertocci B, Da Prada M.
    Eur J Pharmacol; 1990 Sep 04; 186(1):95-104. PubMed ID: 2149340
    [Abstract] [Full Text] [Related]

  • 16. Biochemical profile of risperidone, a new antipsychotic.
    Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA.
    J Pharmacol Exp Ther; 1988 Nov 04; 247(2):661-70. PubMed ID: 2460616
    [Abstract] [Full Text] [Related]

  • 17. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA, Pollock NJ, Frail DE, Paxson CL, Rakowski RF, Kang CH, Kebabian JW.
    Br J Pharmacol; 1991 Dec 04; 104(4):1038-44. PubMed ID: 1687364
    [Abstract] [Full Text] [Related]

  • 18. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O, Parkinson D, Nielsen M.
    Eur J Pharmacol; 1987 Jun 04; 137(2-3):241-5. PubMed ID: 2886353
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.